Izaflortaucipir F-18 clinical trials
Also written [18F]PI-2620.
How each study uses izaflortaucipir F-18 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the izaflortaucipir F-18 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 3
Jae Seung Kim (1) · Genentech, Inc. (1) · Asan Medical Center (1) · Lantheus Biosciences Ltd. (1) · Michael J. Fox Foundation for Parkinson's Research (1) · Life Molecular Imaging SA (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test izaflortaucipir F-18.
- Apr 2027Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's DiseasePhase 2 · Michael J. Fox Foundation for Parkinson's Research
Studies
Open first, then newest update. How each study uses izaflortaucipir F-18 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- [18F]PI-2620 Phase 3 Histopathological StudyRecruitingPhase 3Lantheus Biosciences Ltd.NCT05641688Written as [18F]PI-2620How we know
- Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's DiseaseRecruitingPhase 2Michael J. Fox Foundation for Parkinson's ResearchNCT07020026Written as [18F]PI-2620How we know
- Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain InjuryTerminatedPhase 1Life Molecular Imaging SANCT05337774Written as [18F]PI-2620How we know
- Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's DiseaseCompletedPhase 2Jae Seung KimNCT03903211Written as [18F]PI-2620How we know
- Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's DiseaseCompletedPhase 1Genentech, Inc.NCT04566003Written as [18F]PI-2620How we know
- Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the BrainCompletedEarly Phase 1Asan Medical CenterNCT03510572Written as [18F]PI-2620How we know
Codes
What other systems call izaflortaucipir F-18 · ClinicalTrials.gg INT018097
- UNII (FDA) U796G75A7PIZAFLORTAUCIPIR F-18One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | U796G75A7P | IZAFLORTAUCIPIR F-18 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.